Dr. Chong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Avenue
MC4076
Chicago, IL 60637Phone+1 773-834-1288Fax+1 773-834-1370
Summary
- Dr. Bradford Chong is a gastroenterologist in Chicago, IL. He received his medical degree from Rush Medical College of Rush University Medical Center. He specializes in general gastroenterology, pancreas disease, and early detection for pancreatic cancer.
Education & Training
- Mayo ClinicPancreatology, 2022 - 2023
- Oregon Health & Science University (OHSU Health)Fellowship, Gastroenterology, 2019 - 2022
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2016 - 2019
- Rush Medical College of Rush University Medical CenterClass of 2016, MD
- Northwestern UniversityBS, Human Communication Sciences, 2006 - 2010
Certifications & Licensure
- IL State Medical License 2023 - 2026
- OR State Medical License 2019 - 2025
- MN State Medical License 2022 - 2023
- CA State Medical License 2018 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Chief Fellow Oregon Health and Science University Division of Gastroenterology and Hepatology, 2022
- Pancreas Scholar Collaborative Alliance for Pancreatic Education and Research (CAPER), 2021
- Fellow National Pancreas Foundation, 2020
- Join now to see all
Publications & Presentations
PubMed
- 52 citationsThe Pancreatitis Activity Scoring System predicts clinical outcomes in acute pancreatitis: findings from a prospective cohort studyJames Buxbaum, Michael Quezada, Bradford Chong, Nikhil Gupta, Chung Yao Yu
The American Journal of Gastroenterology. 2018-03-15 - 12 citationsAn Unsuccessful Randomized Trial of Percutaneous vs Endoscopic Drainage of Suspected Malignant Hilar ObstructionB. Joseph Elmunzer, Zachary L. Smith, Paul R. Tarnasky, Andrew Y. Wang, Patrick Yachimski
Clinical Gastroenterology and Hepatology. 2021-06-01 - 25 citationsPercutaneous transhepatic vs. endoscopic retrograde biliary drainage for suspected malignant hilar obstruction: study protocol for a randomized controlled trialFiras H. Al-Kawas, Harry R. Aslanian, John Baillie, F. Banovac, Jonathan M. Buscaglia
Trials. 2018-02-14
Journal Articles
- Hurdles in ERCP Trials: Do We Need to Change the Diagnostic Criteria for Post-ERCP Pancreatitis?Bradford Chong, Gregory A Cote, Clinical Gastroenterology and Hepatology, 10/2021
Professional Memberships
- Member
- Member
- American Pancreatic AssociationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: